1. Home
  2. PHVS vs THR Comparison

PHVS vs THR Comparison

Compare PHVS & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • THR
  • Stock Information
  • Founded
  • PHVS 2015
  • THR 1954
  • Country
  • PHVS Switzerland
  • THR United States
  • Employees
  • PHVS N/A
  • THR N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • THR Industrial Machinery/Components
  • Sector
  • PHVS Health Care
  • THR Energy
  • Exchange
  • PHVS Nasdaq
  • THR Nasdaq
  • Market Cap
  • PHVS 980.3M
  • THR 906.5M
  • IPO Year
  • PHVS 2021
  • THR 2011
  • Fundamental
  • Price
  • PHVS $17.07
  • THR $28.13
  • Analyst Decision
  • PHVS Buy
  • THR
  • Analyst Count
  • PHVS 6
  • THR 0
  • Target Price
  • PHVS $37.17
  • THR N/A
  • AVG Volume (30 Days)
  • PHVS 54.0K
  • THR 222.7K
  • Earning Date
  • PHVS 08-13-2025
  • THR 08-06-2025
  • Dividend Yield
  • PHVS N/A
  • THR N/A
  • EPS Growth
  • PHVS N/A
  • THR 3.97
  • EPS
  • PHVS N/A
  • THR 1.57
  • Revenue
  • PHVS N/A
  • THR $498,207,000.00
  • Revenue This Year
  • PHVS N/A
  • THR $6.11
  • Revenue Next Year
  • PHVS N/A
  • THR $5.40
  • P/E Ratio
  • PHVS N/A
  • THR $17.69
  • Revenue Growth
  • PHVS N/A
  • THR 0.72
  • 52 Week Low
  • PHVS $11.51
  • THR $23.05
  • 52 Week High
  • PHVS $25.50
  • THR $34.36
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 50.14
  • THR 55.72
  • Support Level
  • PHVS $16.78
  • THR $27.03
  • Resistance Level
  • PHVS $17.53
  • THR $27.70
  • Average True Range (ATR)
  • PHVS 1.09
  • THR 0.64
  • MACD
  • PHVS 0.00
  • THR 0.05
  • Stochastic Oscillator
  • PHVS 29.50
  • THR 86.84

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About THR Thermon Group Holdings Inc.

Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.

Share on Social Networks: